Pfizer Inc (NYSE:PFE)
| 38.04 Delayed Data As of 3:59pm ET |  +0.02 / +0.05%Today’s Change | 36.17 Today|||52-Week Range 54.93 | -25.76% Year-to-Date |
Latest PFE News | Press Releases
| Pfizer (PFE) Down 1.1% Since Last Earnings Report: Can It Rebound? 11:31am / Zacks.com - Paid Partner Content | Pfizer (PFE) Posts Upbeat Data From Hemophilia Drug Study May 31 / Zacks.com - Paid Partner Content |
| Biohaven (BHVN) Stock up 8% on Encouraging Pipeline Updates 11:29am / Zacks.com - Paid Partner Content | Does Pfizer Have a Weight-Loss Pill That's Better Than Ozempic? May 31 / MotleyFool.com - Paid Partner Content |
| Have $2,000? 2 Remarkable Growth Stocks to Buy Right Now 7:45am / MotleyFool.com - Paid Partner Content | Pyxis (PYXS) Up on Advancing Cancer Therapy Candidates May 31 / Zacks.com - Paid Partner Content |
| Pfizer's (PFE) RSV Vaccine for Older Adults Gets FDA Approval 7:39am / Zacks.com - Paid Partner Content | 2 Newly Minted AI Stocks to Buy Right Now May 31 / MotleyFool.com - Paid Partner Content |
| Why Pfizer Stock Is Perking Up Today May 31 / MotleyFool.com - Paid Partner Content | 2 Ultra-Safe Dividend Stocks to Load Up On Right Now May 31 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 38.02 |
| Today’s open | 38.16 |
| Day’s range | 37.70 - 38.20 |
| Volume | 19,293,444 |
| Average volume (3 months) | 24,101,955 |
| Market cap | $212.3B |
Data as of 3:59pm ET, 06/01/2023
Growth & Valuation
| Earnings growth (last year) | +41.45% |
| Earnings growth (this year) | -49.31% |
| Earnings growth (next 5 years) | -1.00% |
| Revenue growth (last year) | +23.43% |
| P/E ratio | 7.5 |
| Price/Sales | 2.93 |
| Price/Book | 2.21 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AZNAstraZeneca | -0.23 | -0.32% |
| NVSNovartis | +0.86 | +0.89% |
| ABBVAbbVie | -4.51 | -3.27% |
| NVONovo Nordisk | -2.47 | -1.54% |
Data as of 4:00pm ET, 06/01/2023
Financials
| Next reporting date | August 1, 2023 |
| EPS forecast (this quarter) | $0.62 |
| Annual revenue (last year) | $100.3B |
| Annual profit (last year) | $31.4B |
| Net profit margin | 31.26% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
